Advertisement

Topics

Latest "ProEthic Pharmaceuticals" News Stories

12:06 EST 13th December 2017 | BioPortfolio

Here are the most relevant search results for "ProEthic Pharmaceuticals" found in our extensive news archives from over 250 global news sources.

More Information about ProEthic Pharmaceuticals on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about ProEthic Pharmaceuticals for you to read. Along with our medical data and news we also list ProEthic Pharmaceuticals Clinical Trials, which are updated daily. BioPortfolio also has a large database of ProEthic Pharmaceuticals Companies for you to search.

Showing "ProEthic Pharmaceuticals" News Articles 1–25 of 9,400+

Relevant

Deals this week: Pivot Pharmaceuticals, Innovation Pharmaceuticals, Portola Pharmaceuticals

Pivot Pharmaceuticals plans to acquire the worldwide rights to Altum Pharmaceuticals’ BiPhasix Transdermal drug delivery technology.


Salix Pharmaceuticals (SLXP) vs. Its Rivals Head to Head Survey

Salix Pharmaceuticals is one of 19 public companies in the "Specialty & Advanced Pharmaceuticals" industry, but how does it contrast to its rivals? We will compare Salix Pharmaceuticals to related companies based on the strength of its profitability, dividends, institutional ownership, analyst recommendations, risk, valuation and earnings. Salix Pharmaceuticals' rivals have higher revenue ...

Financial Contrast: Arena Pharmaceuticals

Arena Pharmaceuticals and Sunesis Pharmaceuticals are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, dividends, valuation, risk, earnings, profitability and institutional ownership. Arena Pharmaceuticals has a beta of 1.44, suggesting that its stock price is 44% more volatile than the ...


Inotek Pharmaceuticals announces merger deal with Rocket Pharmaceuticals

Inotek Pharmaceuticals announced that it has entered into a definitive merger agreement with US-based gene therapy company Rocket Pharmaceuticals.

GW Pharmaceuticals plc: GW Pharmaceuticals Announces Proposed Public Offering of ADSs

LONDON, 2017-12-05 22:17 CET (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq:GWPH) ("GW" or the "Company"), a biopharmaceutical company focused on discovering, developing and commercializing nov...

Probably Relevant

Contrasting Pacira Pharmaceuticals

Pacira Pharmaceuticals and Lannett Co are both small-cap pharmaceuticals - nec companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, dividends, risk, valuation, profitability, analyst recommendations and institutional ownership. This is a summary of current ratings and target prices for Pacira Pharmaceuticals and Lannett Co, as r...

GW Pharmaceuticals plc: GW Pharmaceuticals kündigt geplantes öffentliches Angebot von American Depositary Shares an

LONDON, 7. Dez. 2017 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (Nasdaq:GWPH) ("GW" oder das "Unternehmen"), ein biopharmazeutisches Unternehmen, das auf die Entdeckung, Entwicklung und Vermarktun...

Easton Pharmaceuticals Announces That Its Partner Windsor Pharmaceuticals Has Received Regulatory Approvals For Products VS-Sense and AL-Sense For Central America and The Caribbean

TORONTO, ON -- (Marketwired) -- 09/12/17 -- Easton Pharmaceuticals Inc. (OTC PINK: EAPH) and its JV partner BMV Medica SA de CV announces that its distributor Windsor Pharmaceuticals SA has receiv...

Cerecor to acquire TRx Pharmaceuticals

Cerecor has entered into an agreement to TRx Pharmaceuticals and its subsidiary Zylera Pharmaceuticals.

Imprimis launches Surface Pharmaceuticals subsidiary

Imprimis Pharmaceuticals, an ophthalmology-focused pharmaceutical company, has filed a Form 8-K with the SEC which contains a corporate presentation for its subsidiary, Surface Pharmaceuticals. Surface Pharmaceuticals intends to advance state of the art treatments for ocular surface diseases by seeking FDA approval for three drug candidates for up to five indications. Surface’s drug candid...

Ritter Pharmaceuticals Reports Second Quarter 2017 Financial Results and Provides Business Update

LOS ANGELES, CA -- (Marketwired) -- 08/07/17 -- Ritter Pharmaceuticals, Inc. (NASDAQ: RTTR) ("Ritter Pharmaceuticals" or the "Company"), a leading developer of novel therapeutic products that modu...

FDA Grants Cosmo Pharmaceuticals Both QIDP and Fast Track Designations for Aemcolo (Rifamycin SV MMX) for Travelers' Diarrhea

Upon FDA Approval, Aries Pharmaceuticals, Inc. to Lead U.S. Commercial Efforts Cosmo Pharmaceuticals N.V. (SIX: COPN) today announced that the U.S. Food and Drug Administration (FDA) has granted b...

Deals this week: Valeant Pharmaceuticals International, Novan, Recursion Pharmaceuticals

Valeant Pharmaceuticals International plans to raise C$1bn ($801.37m) through the private placement of senior secured notes.

Contrasting Acura Pharmaceuticals (ACUR) & Avadel...

Acura Pharmaceuticals and Avadel Pharmaceuticals plc - American Depositary Shares each representing one Ordinary Share are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, earnings, risk, profitability, dividends, valuation and analyst recommendations. 9.4% of Acura Pharmaceuticals shar...

Easton Pharmaceuticals Announces That Its Partner Windsor Pharmaceuticals Has Received ...

TORONTO, ON--(Marketwired - Sep 12, 2017) -  Easton Pharmaceuticals Inc. ( OTC PINK : EAPH) and its JV partner BMV Medica SA de CV Read more...

Immune Pharmaceuticals Inc.: Immune Pharmaceuticals Appoints John Zhang, MD, Ph.D. as Vice President, Research and Development

ENGLEWOOD CLIFFS, NJ / ACCESSWIRE / December 11, 2017 / Immune Pharmaceuticals Inc. (NASDAQ: IMNP) (the "Company"), a biopharmaceutical company developing novel therapeutic agents for the treatment...

Pivot Pharmaceuticals Inc.: Pivot Pharmaceuticals Obtains Receipt from BCSC for Final Non-Offering Prospectus

VANCOUVER, BC / ACCESSWIRE / December 1, 2017 / Pivot Pharmaceuticals Inc. (OTCQB: PVOTF) ("Pivot" or the "Company"), an emerging biopharmaceutical company engaged in the development and commercial...

Valeant Pharmaceuticals signs deal to sell Sprout Pharmaceuticals subsidiary

Valeant Pharmaceuticals International Inc. has signed a deal to sell its Sprout Pharmaceuticals subsidiary and its female sexual dysfunction drug to the company's former owners. Under the deal, Valeant will receive a six per cent royalty on sales of Addyi starting 18 months from the signing of the sale agreement.

Nasdaq Stockholm AB: Resumed trading in Immune Pharmaceuticals Inc. (329/17)

With reference to a press release published by Immune Pharmaceuticals Inc. today on November 13, 2017, at 16:45 CET, the trading in the shares of Immune Pharmaceuticals Inc. (IMNP, ISIN code US4525...

TEVA Pharmaceuticals: Endlich neuen Chef gefunden - Wieder Fantasie in der Aktie! Aktienanalyse

Schwarzach am Main - TEVA Pharmaceuticals-Aktienanalyse von "ZertifikateJournal": Der mit Problemen kämpfende weltgrößte Generika-Hersteller TEVA Pharmaceuticals (ISIN: US8816242098, WKN: 883035, T...

Comparing Acura Pharmaceuticals

Acura Pharmaceuticals and Flamel Technologies are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their risk, valuation, analyst recommendations, dividends, institutional ownership, profitabiliy and earnings. Acura Pharmaceuticals has a beta of 2.12, indicating that its share price is 112% more volatile than the S&...

Deals this week: Revance Therapeutics, GW Pharmaceuticals, Valeant Pharmaceuticals International

Revance Therapeutics intends to raise $175m through an underwritten public offering of the shares of its common stock. Underwriters will...Read More... The post Deals this week: Revance Therapeutics, GW Pharmaceuticals, Valeant Pharmaceuticals International appeared first on Pharmaceutical Technology.

Valeant to divest Sprout Pharmaceuticals to former owners

Valeant Pharmaceuticals International's affiliate has agreed to divest its female libido-pill business Sprout Pharmaceuticals to a buyer associated with the latter’s former shareholders.

Opiant Pharmaceuticals & Titan Pharmaceuticals to Explore New Approach to Opioid Use Disorder Treatment

NewsRelapse and fatal overdose among those with opioid use disorder is significantly higher than any other type of drug addiction.

Injectable Products by SCA Pharmaceuticals: Recall - Potential Contamination

[Posted 10/21/2017] AUDIENCE: Pharmacy, Health Professional ISSUE: SCA Pharmaceuticals LLC (“SCA Pharmaceuticals”) is voluntarily recalling various lots of injectable products to the hospital level. The is a potential for the products to...


Quick Search
Advertisement
 

News Quicklinks